NATERA, INC. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
NATERA, INC. (NTRA) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt of $82.87 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt · last filed 2023-03-01
- NATERA, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-12-31 was $0.00.
- NATERA, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-09-30 was $0.00.
- NATERA, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-06-30 was $82.87M.
- NATERA, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2020 was $82.87M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 3 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 6 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 9 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $82.87M derived: sum of 3 quarters · filed 2023-03-01 | $82.87M 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $82.87M derived: sum of 2 quarters · filed 2021-11-05 | $82.87M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $82.87M 10-Q · filed 2021-08-06 | $82.87M 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |